This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Autophagysciences Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Seung Hyun Oh: Innovator in Autophagy-Related Therapeutics
Introduction
Seung Hyun Oh is a notable inventor based in Goyang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of autophagy-related diseases. His innovative work has led to the development of a unique compound that holds promise for medical applications.
Latest Patents
Seung Hyun Oh holds a patent for a catechol derivative and a pharmaceutical composition comprising the same. This invention relates to a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof. The compound can be effectively utilized for the prevention or treatment of autophagy-related diseases, showcasing its potential therapeutic benefits.
Career Highlights
Seung Hyun Oh is associated with Autophagy Sciences Inc., where he continues to advance research in his field. His work is characterized by a commitment to developing innovative solutions that address critical health challenges.
Collaborations
Seung Hyun Oh collaborates with Hwan Mook Kim, contributing to the advancement of their shared research interests. Their partnership exemplifies the collaborative spirit that drives innovation in the pharmaceutical industry.
Conclusion
Seung Hyun Oh's contributions to the field of autophagy-related therapeutics highlight his role as a key inventor. His patent for a catechol derivative represents a significant step forward in the treatment of related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile